Results 61 to 70 of about 51,672 (208)
Mining directional drug interaction effects on myopathy using the FAERS database [PDF]
, 2018 Mining high-order drug-drug interaction (DDI) induced adverse drug effects from electronic health record (EHR) databases is an emerging area, and very few studies have explored the relationships between high-order drug combinations.
Chasioti, Danai +7 more
core +1 more source
مجله دانشگاه علوم پزشکی بیرجند, 2018 Background and Aim: For the treatment of osteoporosis, bisphosphonates are commonly used as oral or injectable compounds. This study was conducted with the aim of comparing the effect of oral alendronate with injectable pamidronate on bone density ...
Zohre Nobakht +2 more
doaj
Stem Cell Research & Therapy, 2018 Background Hyperbilirubinemia that occurs in pediatric liver diseases such as biliary atresia can result in the development of not only jaundice in the brain, eyes, and skin, but also tooth abnormalities including green pigmentation and dentin hypoplasia
Haruyoshi Yamaza +4 more
doaj +1 more source
Recent Developments in Osteogenesis Imperfecta [PDF]
, 2015 Osteogenesis imperfecta (OI) is an uncommon genetic bone disease associated with brittle bones and fractures in children and adults. Although OI is most commonly associated with mutations of the genes for type I collagen, many other genes (some ...
Albert, Carolyne +3 more
core +2 more sources
Fanconi Syndrome After a Single Exposure to Intravenous Zoledronic Acid
Clinical Case Reports, Volume 14, Issue 2, February 2026.ABSTRACT Bisphosphonates are commonly used to reduce fracture risk in patients with osteoporosis, in those with malignant metastatic bone disease and for treatment of malignant hypercalcaemia. We present the case of a woman in her 80s admitted with recurrent falls who developed Fanconi syndrome after a single dose of intravenous Zoledronic acid despite
Rita Deb +2 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 1, January 2026.In this retrospective population study containing 139,859 patients, subjects receiving RANK‐ligand inhibitors had improved survival and decreased rates of skeletal‐related events relative to the overall cohort of patients with metastatic bone lesions.
Brian H. Im +9 more
wiley +1 more source
Navigating the evolving management of smoldering multiple myeloma
HemaSphere, Volume 10, Issue 1, January 2026.Abstract Smoldering multiple myeloma (SMM) represents an intermediate clinical stage between monoclonal gammopathy of undetermined significance (MGUS) and symptomatic multiple myeloma (MM). SMM carries a highly variable risk of progression to MM, requiring individualized risk stratification to guide management.
M. Bakri Hammami +6 more
wiley +1 more source
A case of chronic recurrent multifocal osteomyelitis associated with Crohn's disease [PDF]
, 2015 Chronic recurrent multifocal osteomyelitis (CRMO) is an auto-inflammatory bone disease of unknown etiology, most commonly affecting the metaphysis of long bones, especially the tibia, femur and clavicle. The clinical spectrum varies from self-limited uni-
De Baets, Frans +5 more
core
Bisphosphonate-associated jaws osteonecrosis: an important complication of oncology treatment [PDF]
, 2009 Os bisfosfonatos são um grupo de medicamentos utilizados no tratamento de doenças malignas metastáticas e em outras doenças ósseas como osteoporose e doença de Paget.
GIGLIO, Auro del +4 more
core +1 more source
Adjuvant pharmacological strategies for the musculoskeletal system during long‐term space missions
British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 11-23, January 2026.Abstract Despite 2 h of daily exercise training, muscle wasting and bone loss are still present after 6‐month missions to the international space station. Some crew members lose bone much faster than others. In preparation for missions to the Moon and Mars, space agencies are therefore reviewing their countermeasure portfolios.
Friederike Thomasius +2 more
wiley +1 more source